MONTREAL, Feb. 27, 2014 /CNW Telbec/ - Rolaids is back, and the timing
couldn't be better. According to a new survey released today, this is
the season when many Canadians experience stress and heartburn.
A new survey conducted by Ipsos and commissioned by Sanofi Canada,
reveals that 54% of Canadians who suffer from heartburn at least once a
month say they feel the most stressed during the January-March
period. In addition, 36% polled said they suffer from the worst
heartburn during the same period.
Starting today, Rolaids can now be found once more in retail stores
across the country. Sanofi Canada is re-introducing the popular antacid
following the company's acquisition of the brand.
What are the top heartburn-causing events during the January-March
period? By a huge margin, the number-one factor is overindulging in
heavy meals (48%). The next stated reason is being fed up with the long
cold Canadian winter (7%), followed by having to pay all the bills
after the holidays (5%).
"This is a particularly trying time of year for many Canadians," says
Jon Fairest, President and CEO of Sanofi Canada. "We are happy that
Canadians can turn to Rolaids once again for heartburn relief."
Sanofi Canada will support the re-launch of Rolaids with Canadian-made
television spots and a social media campaign starting this spring,
featuring some of this country's funniest comedians providing a daily
moment of Rolaids Relief.
Approximately a quarter of the population (24%) or 8 million Canadians,
experience heartburn daily, or more often.1 Heartburn occurs when the opening between the stomach and esophagus
malfunctions, allowing stomach acid to enter the esophagus. Rolaids
works by reducing stomach acid and relieving the burning sensation.
Rolaids was first introduced 60 years ago. Irvine W. Grote patented one
of the active ingredients used in the original formulation while
serving as the head of the chemistry department at what is now the
University of Tennessee, Chattanooga. In the 1970s, Rolaids'
advertising campaign became famous for the tagline: How do you spell relief? R-O-L-A-I-D-S.
Rolaids is available in tablet form along with a new Ultra Strength
formulation which delivers Rolaids' strongest level of acid
neutralization. Rolaids is a national brand antacid to offer a
dual-action formula of calcium and magnesium to effectively relieve
To find out more information about Rolaids, please visit www.rolaids.ca.
The full Ipsos survey report is available at: Ipsos survey
Sanofi, an integrated global healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs. Sanofi
has core strengths in the field of healthcare with seven growth
platforms: diabetes solutions, human vaccines, innovative drugs,
consumer healthcare, emerging markets, animal health and the new
Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York
Sanofi entities in Canada include Sanofi Canada (pharmaceuticals),
Sanofi Pasteur (vaccines), Sanofi Consumer Health (health and beauty),
Genzyme (rare diseases) and Merial (animal health). Together they
employ more than 1,700 people across the country. In 2012 Sanofi
companies invested $122 million in R&D in Canada, creating jobs,
business and opportunity throughout the country.
1 Tytgat GN, McColl K, Tack J et al. New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008;27(3):249-56.
PDF available at: http://stream1.newswire.ca/media/2014/02/27/20140227_C7775_DOC_EN_37196.pdf
SOURCE: Sanofi Canada
For further information:
For interviews, contact: